Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUTYLSCOPOLAMINE Cause Toxicity to various agents? 51 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Toxicity to various agents have been filed in association with BUTYLSCOPOLAMINE. This represents 6.0% of all adverse event reports for BUTYLSCOPOLAMINE.

51
Reports of Toxicity to various agents with BUTYLSCOPOLAMINE
6.0%
of all BUTYLSCOPOLAMINE reports
37
Deaths
15
Hospitalizations

How Dangerous Is Toxicity to various agents From BUTYLSCOPOLAMINE?

Of the 51 reports, 37 (72.5%) resulted in death, 15 (29.4%) required hospitalization.

Is Toxicity to various agents Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUTYLSCOPOLAMINE. However, 51 reports have been filed with the FAERS database.

What Other Side Effects Does BUTYLSCOPOLAMINE Cause?

Drug ineffective (178) Headache (103) Off label use (103) Hypersensitivity (99) Swelling face (89) Drug ineffective for unapproved indication (85) Vomiting (84) Swollen tongue (82) Angioedema (81) Drug abuse (81)

What Other Drugs Cause Toxicity to various agents?

OXYCODONE (17,518) ACETAMINOPHEN (16,128) FENTANYL (15,546) MORPHINE (15,337) BUPRENORPHINE (10,906) HYDROMORPHONE (10,769) HYDROCODONE (10,645) ACETAMINOPHEN\OXYCODONE (10,568) ACETAMINOPHEN\HYDROCODONE (10,343) TAPENTADOL (9,617)

Which BUTYLSCOPOLAMINE Alternatives Have Lower Toxicity to various agents Risk?

BUTYLSCOPOLAMINE vs BYDUREON BUTYLSCOPOLAMINE vs BYETTA BUTYLSCOPOLAMINE vs BYETTA PEN DISPOSABLE BUTYLSCOPOLAMINE vs CABAZITAXEL BUTYLSCOPOLAMINE vs CABERGOLINE

Related Pages

BUTYLSCOPOLAMINE Full Profile All Toxicity to various agents Reports All Drugs Causing Toxicity to various agents BUTYLSCOPOLAMINE Demographics